This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sasaki, A. Articles by Herberman, R. B. Search for Related Content PubMed PubMed Citation Articles by Sasaki, A. Articles by Herberman, R. B.

Low Deformability of Lymphokine-activated Killer Cells as a Possible Determinant of in Vivo Distribution¹

Tumor Microcirculation Laboratory, Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213-3890 [A. S., R. K. J.], and Pittsburgh Cancer Institute, and Department of Pathology and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-2592 [A. A. M., R. H. G., R. B. H.]

Successful therapy of tumors with lymphokine-activated killer (LAK) cells is presumably dependent on their cytolytic potential and their gaining access to the target cells through the microcirculation. The latter process involves dissemination through the microvessels, adhesion to the venular walls, and extravasation through them, all of which depend on the size and deformability of these effector cells. The aim of the present study was to measure the deformability of these cells quantitatively using a micropipet aspiration technique and to analyze the deformation data using a mathematical model which yielded parameters indicative of the rigidity of the cell membrane and the cytoplasm. Adherent rat LAK cells, consisting of a highly purified population of interleukin 2-activated large granular lymphocytes, with high cytotoxicity were obtained by a recently developed method. The deformability characteristics of fresh large granular lymphocytes (mean diameter, 7.2 µm), LAK cells (11.0 µm), fresh T-cells (6.6 µm), and concanavalin A-activated T-cells (9.7 µm) were compared. LAK cells were significantly less deformable than other cell types [about one-half at an aspiration pressure of -25 mm of H₂O (P < 0.001)]. Cell deformability was independent of cell size and calcium content of the medium. Analysis of the data with the mathematical model suggested that both the cell membrane and the cytoplasmic factors contributed to the rigidity of LAK cells. This increased rigidity coupled with their large cell size may explain high retention of LAK cells in the lungs immediately after i.v. injection and a reduction in tumor targetting due to external radiation. Finally, these results suggest that LAK cell therapy might be enhanced by intraarterial injection into an organ infiltrated by tumor metastases.

¹ Supported by the National Science Foundation and the American Cancer Society. This work was presented at the FASEB Meeting, May 2–5, 1988, Las Vegas, NV, and at the Radiation Research Society Meeting, March 20–23, 1989, Seattle, WA.

² Recipient of a fellowship from the Japanese Agency of Science and Technology (1987–1988).

³ To whom requests for reprints should be addressed.

Received 2/ 8/89. Accepted 4/10/89.

This article has been cited by other articles:

				T. J. Zieziulewicz, D. W. Unfricht, N. Hadjout, M. A. Lynes, and D. A. Lawrence Shrinking the Biologic World--Nanobiotechnologies for Toxicology Toxicol. Sci., August 1, 2003; 74(2): 235 - 244. [Abstract] [Full Text] [PDF]

				J. Kjaergaard and S. Shu Tumor Infiltration by Adoptively Transferred T Cells Is Independent of Immunologic Specificity but Requires Down-Regulation of L-Selectin Expression J. Immunol., July 15, 1999; 163(2): 751 - 759. [Abstract] [Full Text] [PDF]